Investor Overview

Corporate Profile

Investor Highlights

Corporate Profile

Read Now
Corporate Profile

2018 Investor Presentation

Read Now
highlightbg1

Our Pipeline

Learn More
highlightbg2
  • Price
  • Change

  • Copyright West LLC.
    Minimum 15 minutes delayed.
Recent Releases

Recent Releases

April 9, 2019

BioAtla and BeiGene Form Worldwide Collaboration to Develop and Commercialize Novel Conditionally Active Biologic CTLA-4 Therapy

April 1, 2019

BeiGene Announces Phase 1 Long-Term Exposure Data and Results from Structural and Mechanistic Analyses on Tislelizumab at the AACR Annual Meeting

March 6, 2019

Ambrx and BeiGene Announce Global Research and Development Collaboration to Develop Next-Generation Biologics

Key Metrics

Key Metrics

  • 2,200

    Employees

  • 800+

    Clinical team

  • 4

    Continents

Latest Events

Mar 13, 2019 at 3:20 PM EDT

BeiGene, Ltd. at the Barclay’s Global Healthcare Conference

Mar 11, 2019 at 4:10 PM EDT

BeiGene, Ltd. at the Cowen and Company 39th Annual Health Care Conference

This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.

Accept